GC expression levels of METTL3 [106], METTL14 [80], ALKBH1 [104], WTAP [105], IGF2BP1/2/3 [97], and METTL15 [107] relate to GC patient prognosis. This evidence concerns the gene METTL3 and gastric cancer.